Deventer Sander van Insider Trading $ARGS ARGOS THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Deventer Sander van.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deventer Sander van. Deventer Sander van is Director in ARGOS THERAPEUTICS INC ($ARGS) and Chief Scientific Officer in uniQure N.V. ($QURE) and Director in uniQure N.V. ($QURE) and EVP, Research & Product Dev. in uniQure N.V. ($QURE) and Director in HOOKIPA Pharma Inc. ($HOOK).
Deventer Sander van in ARGOS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deventer Sander van: Director
Holdings: 5,057 shares
Current Value: $24,526
Latest Transaction: Jan 20 2017
$ARGS Market Capitalization: $208.29M
$ARGS Previous Close: $4.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Deventer Sander van in ARGOS THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARGS, HOOK, QURE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2017 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | A | 4.85 | 9,500 | 46,075 | 9,500 | |
| Oct 03 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Grant | A | 0.00 | 2,263 | 0 | 5,057 | 2.8 K to 5.1 K (+80.99 %) |
| Aug 04 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | P | 5.50 | 1,159,090 | 6,374,995 | 1,159,090 | |
| Aug 04 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | P | 0.00 | 1,545,454 | 0 | 6,199,961 | 4.7 M to 6.2 M (+33.20 %) |
| Jul 05 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Grant | A | 0.00 | 1,427 | 0 | 2,794 | 1.4 K to 2.8 K (+104.39 %) |
| Jul 01 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | P | 5.35 | 991,964 | 5,307,007 | 991,964 | |
| Jul 01 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | P | 0.00 | 1,322,618 | 0 | 4,654,507 | 3.3 M to 4.7 M (+39.70 %) |
| Jun 14 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | A | 7.41 | 5,500 | 40,755 | 5,500 | |
| Apr 04 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Grant | A | 0.00 | 1,367 | 0 | 1,367 | 0 to 1.4 K |
| Mar 16 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | P | 5.35 | 661,309 | 3,538,003 | 661,309 | |
| Mar 16 2016 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | P | 0.00 | 881,745 | 0 | 3,331,889 | 2.5 M to 3.3 M (+35.99 %) |
| Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 5,500 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | C | 0.00 | 1,428,888 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | C | 0.00 | 984,840 | 0 | 0 | |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | P | 8.00 | 36,416 | 291,328 | 2,450,144 | 2.4 M to 2.5 M (+1.51 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | C | 0.00 | 1,428,888 | 0 | 2,413,728 | 984.8 K to 2.4 M (+145.09 %) |
| Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | C | 0.00 | 984,840 | 0 | 984,840 | 0 to 984.8 K |
Page: 1